Clinical trial
Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute…
NCT00488618 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00488618 |
|---|---|
| Title | Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania |
| Official title | A Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of RGH-188 in Patients With Acute Mania Associated With Bipolar I Disorder |
| Lead sponsor | Forest Laboratories, Industry |
| Collaborators | Gedeon Richter Ltd. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Cariprazine (RGH-188), Placebo |
| Enrollment | 238 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Jun 20, 2007 |
| Last update posted | Apr 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: